Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001745020-23-000039
Filing Date
2023-06-13
Accepted
2023-06-13 17:30:02
Documents
1
Period of Report
2023-06-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1686691788.html 4  
1 FORM 4 wk-form4_1686691788.xml 4 6554
  Complete submission text file 0001745020-23-000039.txt   7918
Mailing Address 501 CANAL BLVD. POINT RICHMOND TECH CENTER RICHMOND CA 94804
Business Address
Yi Kathy (Reporting) CIK: 0001697802 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40869 | Film No.: 231012285

Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Issuer) CIK: 0001745020 (see all company filings)

EIN.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations